Target intelligence / Profile preview

Fc gamma receptor and complement receptor (FcγR/CR)

Target
FcγR/CR
Molecular classification
Receptor, Immunoglobulin superfamily, Integrin family, Cell surface protein
01

Overview

Fc gamma receptors (FcγRs) and complement receptors (CRs) are critical surface proteins expressed on antigen-presenting cells (APCs), such as macrophages, dendritic cells, and B cells (Nimmerjahn & Ravetch, 2008, Nature Reviews Immunology). FcγRs specifically recognize the Fc portion of immunoglobulin G (IgG) antibodies, while CRs bind to fragments of the complement system, such as C3b and iC3b, that coat pathogens or immune complexes (Ricklin et al., 2010, Nature Immunology). Together, these receptors mediate the internalization of opsonized antigens, a process essential for efficient antigen processing and subsequent presentation to T cells (Guilliams et al., 2014, Nature Reviews Immunology). This interaction bridges the innate and adaptive immune systems, regulating the threshold for immune activation and the clearance of debris. In disease contexts, dysregulation of these receptors is linked to autoimmune disorders like systemic lupus erythematosus (SLE), where impaired immune complex clearance leads to tissue damage (Bournazos et al., 2017, Nature Reviews Rheumatology). Conversely, in oncology, many therapeutic monoclonal antibodies, such as Rituximab, rely on FcγR-mediated mechanisms like antibody-dependent cellular cytotoxicity (ADCC) to eliminate tumor cells (Wang et al., 2015, Frontiers in Immunology).

Other names
Fc-gamma receptorsComplement receptorsFcgammaRCRCD16CD32CD64CD35Complement receptor type 1Complement receptor type 3CD11b/CD18
02

Mechanism of action

Modulation of immune cell activation and phagocytosis through the binding of IgG Fc regions or complement-opsonized antigens, facilitating antigen uptake and processing.

03

Biological functions

Immune responsePhagocytosisAntigen presentationOpsonizationAntibody-dependent cellular cytotoxicityImmune complex clearance
04

Disease associations

Autoimmune diseaseCancerInfectionInflammationSystemic lupus erythematosus
05

Safety considerations

Cytokine release syndromeInfusion-related reactionsImmunosuppressionIncreased susceptibility to pyogenic infectionsParadoxical autoimmunity
06

Interacting drugs

Rituximab

6 more in the full profile.

07

Biomarkers

FCGR3A V158F polymorphismCD64 expressionC3/C4 complement levelsSoluble CD16

Beyond the preview

Go deeper on Fc gamma receptor and complement receptor (FcγR/CR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fc gamma receptor and complement receptor (FcγR/CR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call